{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:34:40Z","timestamp":1773149680219,"version":"3.50.1"},"reference-count":20,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T00:00:00Z","timestamp":1277078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Several Panton\u2010Valentin leukocidin\u2010positive clones of community\u2010acquired methicillin\u2010resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (CA\u2010MRSA) are spreading worldwide. The European clone ST80\u2010IV is the main CA\u2010MRSA clone in Europe. There is no reported study of the specific clinical manifestations and outcome of skin infections caused by the clone ST80\u2010IV, using strict definitions of skin diseases.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Single\u2010centre observational prospective cohort of <jats:italic>S. aureus<\/jats:italic> skin infections caused by the clone ST80\u2010IV.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> From November 1999 to October 2009, we diagnosed skin infections due to the clone ST80\u2010IV in 20 patients (median age 28\u2003years, median 27; range 1\u201366). All the isolates had all the following characteristics: <jats:italic>luk<\/jats:italic>PV, <jats:italic>etd<\/jats:italic> and <jats:italic>edin<\/jats:italic> gene\u2010positive, <jats:italic>agr<\/jats:italic> 3 allele, <jats:italic>spa<\/jats:italic>\u2010type t044 and ST80. All the isolates were resistant to beta\u2010lactam agents, kanamycin, tetracycline and fusidic acid. During the study period, the 20 patients had the following manifestations: 19 primary abscesses (18 single abscess and one patient with two), eight furuncles, four folliculitis, one case of cellulitis, one wound infection and one felon. Surgical treatment and drainage was required for all the primary abscesses. The infections occurred mainly in the perineal area (50%). No secondary infections occurred in family members. Despite strict hygiene measures, systemic antibiotics and nasal mupirocine, four patients (20%) had recurrent skin infections over a period of a few months to 6\u2003years.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The CA\u2010MRSA clone ST80\u2010IV is responsible for suppurative skin infections such as furuncles and abscesses, which can recur over a period of several years.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2010.03731.x","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T10:07:21Z","timestamp":1277114841000},"page":"164-169","source":"Crossref","is-referenced-by-count":16,"title":["Clinical manifestations and outcome of skin infections caused by the community\u2010acquired methicillin\u2010resistant <i>Staphylococcus aureus<\/i> clone ST80\u2010IV"],"prefix":"10.1111","volume":"25","author":[{"given":"P","family":"Del Giudice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Hubiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Roudi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Lina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Vandenesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055356"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-5-200603070-00005"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1304.061316"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"19089","DOI":"10.2807\/ese.14.02.19089-en","article-title":"High rates of community\u2010acquired, Panton\u2010Valentine leukocidin (PVL)\u2010positive methicillin\u2010resistant S. aureus (MRSA) infections in adult outpatients in Greece","volume":"14","author":"Vourli S","year":"2009","journal-title":"Euro Surveill"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-008-0660-x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.1083-1085.2006"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06910.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/497143"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.2.631-641.2002"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.29.10.2240-2244.1991"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.3.1008-1015.2000"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.130.9.1208"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/427290"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08197.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.7.3203-3207.2005"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-005-1354-2"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.10.5835-5845.2002"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01410.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01381-07"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/526773"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2010.03731.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2010.03731.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T02:51:34Z","timestamp":1697338294000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2010.03731.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1111\/j.1468-3083.2010.03731.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03731.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,4]]}}}